MacroGenics | MGNX - Operating Profit



MacroGenics reported $-36760000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
Amgen USD 2.66B 1.37B Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Daiichi Sankyo JPY 96.71B 13.1B Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Genmab DKK 360M 172M Jun/2025
Geron USD -12454000 4.25M Jun/2025
Gilead Sciences USD 2.7B 467M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
MacroGenics USD -36760000 20.17M Jun/2025
Merck USD 6.36B 494M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Regeneron Pharmaceuticals USD 1.08B 487.8M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Xencor USD -33172000 10.01M Jun/2025